InMed Pharmaceuticals (INM) Enterprise Value: 5.455M

InMed Pharmaceuticals, Inc. (INM)

1.44 +0.11 (+8.27%) USD | NASDAQ | Oct 23, 16:00

1.54 +0.10 (+6.94%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2006. Start Trial.

Date	Value
October 23, 2026	5.455M
October 22, 2026	4.867M
October 21, 2026	5.028M
October 20, 2026	4.921M
October 19, 2026	5.056M
October 16, 2026	4.814M
October 15, 2026	4.867M
October 14, 2026	4.760M
October 13, 2026	4.867M
October 12, 2026	5.028M
October 09, 2026	5.028M
October 08, 2026	4.867M
October 07, 2026	4.867M
October 06, 2026	4.867M
October 05, 2026	4.867M
October 02, 2026	4.867M
October 01, 2026	4.974M
September 30, 2026	5.028M
September 29, 2026	5.108M
September 28, 2026	5.028M
September 25, 2026	5.134M
September 24, 2026	5.241M
September 23, 2026	5.134M
September 22, 2026	5.188M
September 21, 2026	5.134M

Date	Value
September 18, 2026	5.028M
September 17, 2026	5.188M
September 16, 2026	4.600M
September 15, 2026	4.600M
September 14, 2026	4.707M
September 11, 2026	4.654M
September 10, 2026	4.760M
September 09, 2026	4.760M
September 08, 2026	4.867M
September 04, 2026	5.134M
September 03, 2026	4.867M
September 02, 2026	4.974M
September 01, 2026	4.814M
August 31, 2026	4.974M
August 28, 2026	5.134M
August 27, 2026	5.401M
August 26, 2026	5.401M
August 25, 2026	5.455M
August 24, 2026	5.401M
August 21, 2026	5.561M
August 20, 2026	6.202M
August 19, 2026	6.256M
August 18, 2026	5.455M
August 17, 2026	5.561M
August 14, 2026	5.615M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks